[1]池嘉昌,沈加林,许建荣,等.全肝CT灌注成像在原发性肝癌TACE术后局部病灶活性评估中的临床应用[J].介入放射学杂志,2010,(07):540.
　CHI Jiachang,SHEN Jialin,XU Jianrong,et al.Clinical application of whole－liver perfusion－enhanced CT imaging in evaluating the activity of residual hepatocellular carcinoma after TACE[J].journal interventional radiology,2010,(07):540.
点击复制

全肝CT灌注成像在原发性肝癌TACE术后局部病灶活性评估中的临床应用()

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2010年07期
页码:
540
栏目:
肿瘤介入
出版日期:
2010-07-15

文章信息/Info

Title:
Clinical application of whole－liver perfusion－enhanced CT imaging in evaluating the activity of residual hepatocellular carcinoma after TACE
作者:
池嘉昌; 沈加林; 许建荣; 等
２００１２７上海交通大学医学院附属仁济医院放射科
Author(s):
CHI Jia－chang; SHEN Jia－lin; XU Jian－rong; TANG Rui ; CHENG Jie－jun．
Renji Hospital，School of Medicine，Shanghai Jiaotong University，Shanghai２００１２７，China
关键词:
肝细胞癌; CT灌注成像技术; 栓塞
分类号:
R
文献标志码:
A
摘要:
目的探讨全肝灌注CT增强扫描检查在肝癌TACE术后局部病灶活性评估中的作用。方法３８例行TACE治疗的肝癌患者，术后６周在Siemens１２８排CT上行全肝灌注CT增强扫描和DSA造影。根据全肝灌注扫描图像获得肝脏灌注参数，与DSA造影结果进行对比，以DSA造影作为标准，分别分析CT灌注对TACE术后局部肿瘤活性的显示情况。结果全肝CT灌注共检出病灶４２处（１００％），诊断正确率８８．０９％，灵敏度９４．１１％，特异度６２．５０％，阳性预测值＝９１．４２％；阴性预测值＝７１．４２％；一致性检验Kappa值０．８６１３。TACE术后局部肿瘤生长区的相关灌注参数与非瘤区肝组织的灌注参数，两者的血流量（BF）、血容量（BV）、肝动脉指数（HAI ）和肝门脉灌注（PVP）差异均有统计学意义（P＜０．０１）。结论全肝灌注CT增强扫描能很好的显示肝癌TACE术后局部病灶的活性，在肝癌TACE术后评估中具有较高的应用价值。

参考文献/References:

［１］Zhang JS．TACE combined with other treatment for primary hepatic carcinoma ：current status and the role of interventional radiologist［J］．China J Interv Imaging Ther，２００８，５：８３－８５２．
［２］贾雨辰，程红岩，陈栋，等．原发性肝癌的介入治疗［J］．肝胆外科杂志，１９９８，６：３１６－３１８．
［３］Zhou ZF，Huang HL，Xu B，et al．Clinic application with MSCT perfusion in liver tumor［J］．Linchuang Fangshexue Zazhi ，２００６，２５：２３３－２３７．
［４］黄光明，祖茂衡．CT灌注成像在肝癌TACE术后评估中的应用［J］．中国介入影像与治疗学，２００９，６：６３－６６．
［５］Tsushima Y，Unno Y，Koizumi J，et al．Hepatic perfusion changes after transcatheter arterial embolization（TAE）of hepatocellular carcinoma ：measurement by dynamic computed tomography（CT）［J］．Dig Dis Sci，１９９８，４３：３１７－３２２．
［６］梁文，唐海亮，全显跃，等．６４层螺旋CT全肝灌注模式成像在肝细胞癌中的初步应用［J］．Chin J Med Imaging Technol，２００７，２３：７０７－７０９．
［７］郑加贺，郭启勇，卢再呜，等．CT灌注成像评价肝细胞癌TACE前后血供的初步经脸［J］．中国医学影像学杂志，２００７，１５：５－８．
［８］赵立峰，徐克，苏洪英，等．CT灌注诊断原发性肝癌TACE术后局部肿瘤生长的研究［J］．现代肿瘤医学，２００９，１７：７９－８２．
［９］裴小青，李安华，韩峰，等．超声造影成像对TACE综合治疗肝癌疗效的评判价值与螺旋CT对比分析［J］．中国超声医学杂志，２００５，２１：７６４－７６６．
［１０］商健彪，李彦豪，刘方颖，等．１８F２FDG PET、碘油沉积形式及血清AFP在肝细胞癌介入治疗后疗效评价中的关系［J］．介入放射学杂志，２００４，１３：４２１－４２４．
［１１］尚全良，肖恩华，贺忠，等．肝癌经导管动脉灌注化疗栓塞术疗效的MR扩散加权成像动态研究［J］．中华放射学杂志，２００６，１４０：２３５－２４０．
［１２］Liang Zhong，Wen－Jing Wang，Jian－Rong Xu．Clinical appli－cation of hepatic CT perfusion［J］．World J Gastroenterol，２００９，２８；１５：９０７－９１１．
［１３］陈昆涛，何健垣，郭瑞珍，等．肝癌化疗栓塞前后CT灌注特征与肿瘤血管生成相关性的实验研究［J］．Chin Clin Med Imaging，２００７，１８：５９１－５９３．
［１４］史芳，李凌．VEGF在肝癌TACE联合抗血管治疗及预后中的作用［J］．江西医学院学报，２００９，４９：１３３－１３８．
［１５］肖亦明，杨建勇，江利，等．肝动脉栓塞术后肝脏血流动力学改变的CT灌注成像［J］．广东医药，２００６，２７：７９８－７９９．
［１６］Kan Z，Kobayashi S，Phongkitkarun S，et al．Functional CT quantification of tumor perfusion after transhepatic arterial embolization in a rat model［J］．Radiology，２００５，２３７：１４４－１５０．

相似文献/References:

[1]张绪敬,程佩芳,董光,等.原发性肝癌经导管化疗、栓塞前后血中凝血酶原变化的研究[J].介入放射学杂志,1992,(01):33.
[2]欧阳墉,马和平,张学军,等.肝细胞癌的鉴别诊断——附10例分析[J].介入放射学杂志,1996,(01):40.
[3]王悍 王精兵 张贵祥 王麟川.肝细胞癌动脉化疗栓塞术后并发脑梗死一例[J].介入放射学杂志,2005,(04):442.
　WANG Han WANG Jing-bing ZHANG Gui-xiang WANG Lin-chuan.Cerebral infarction aften transaterial shemoembolization for hepatocellular carcinoma a cage report[J].journal interventional radiology,2005,(07):442.
[4]周斌,李征然,钱结胜,等.原发性肝癌肝移植后肿瘤复发的化疗栓塞治疗[J].介入放射学杂志,2009,(03):185.
　ZHOU Bin,LI Zhengran,QIAN Jiesheng,et al.Chemoembolization for recurrent hepatocellular carcinoma after liver transplantation[J].journal interventional radiology,2009,(07):185.
[5]黄渊全,贾中芝,冯耀良,等.CT灌注成像在肝癌TACE术后疗效评价中的应用价值[J].介入放射学杂志,2009,(06):437.
　HUANG Yuan-quan,JIA Zhong-zhi,FENG Yao-liang,et al.Clinical application of CT perfusion imaging in estimating the efficacy of transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma[J].journal interventional radiology,2009,(07):437.
[6]郭丽萍,张晓玲,王莉娜.经导管肝动脉化疗栓塞联合高强度聚焦超声治疗原发性肝癌的护理[J].介入放射学杂志,2010,(04):328.
　GUO Liping,ZHANG Xiaoling,WANG Lina.The nursing care for patients of hepatocellular carcinoma treated with transcatheter hepatic arterial chemoembolization and high intensive focus ultrasound[J].journal interventional radiology,2010,(07):328.
[7]沈海洋,杨光,刘瑞宝,等.肝右叶前、后段原发性肝癌动脉化疗栓塞术后近期疗效比较[J].介入放射学杂志,2010,(05):382.
　SHEN Haiyang,YANG Guang,LIU Ruibao,et al.Short－term effects of TACE for primary hepatocellular carcinoma of the right hepatic lobe：a comparison between the lesions in anterior segments and the lesions in posterior segments[J].journal interventional radiology,2010,(07):382.
[8]翁志成,杨维竹,江娜,等.CT引导下１２５I放射性粒子植入治疗肝癌门静脉癌栓的疗效评价[J].介入放射学杂志,2010,(07):535.
　WENG Zhicheng,YANG Weizhu,JIANG Na,et al.Evaluation of CT－guided１２５I seed implantation combined with transcatheter arterial chemoem－bolization in treating portal vein tumor thrombus associated with hepatocellular carcinoma[J].journal interventional radiology,2010,(07):535.
[9]王惠文,刘瑞宝,刘　　　岩,等.原发性肝癌ＴＡＣＥ后ＦＡＫ、ＮＦκＢｐ６５表达及意义[J].介入放射学杂志,2011,(08):621.
　WANG Hui-wen,LIU Rui-bao,LIU Yan,et al.The expression and significance of FAK and NF-κBp65 in hepatocellular carcinoma after transcatheter arterial chemoembolization[J].journal interventional radiology,2011,(07):621.
[10]姚雪松,闫 东,曾辉英,等.经动脉化疗栓塞治疗肝细胞癌疗效评估中C臂CT技术应用[J].介入放射学杂志,2014,(07):588.
　YAO Xue- song,YAN Dong,ZENG Hui- ying,et al.The application of C- arm CT imaging technique in evaluating the efficacy of TACE for hepatocellular carcinoma[J].journal interventional radiology,2014,(07):588.

备注/Memo

备注/Memo:
收稿日期：２００９－１１－２４
基金项目：上海市重点学科建设项目资助（编号：S３０２０３）及上海交通大学医学院重点学科
更新日期/Last Update: 2010-07-15